Notice2024-31293

Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 30, 2024

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 249 (Monday, December 30, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Pages 106579-106580]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-31293]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1461]


Bulk Manufacturer of Controlled Substances Application: Irvine 
Labs Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Irvine Labs Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
February 28, 2025. Such persons may also file a written request for a 
hearing on the application on or before February 28, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking

[[Page 106580]]

Number, your comment has been successfully submitted and there is no 
need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 26, 2024, Irvine Labs Inc., 7305 Murdy Circle, 
Huntington Beach, California 92647-3533, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide..............            7315               I
Mescaline...............................            7381               I
Peyote..................................            7415               I
Diethyltryptamine.......................            7434               I
Dimethyltryptamine......................            7435               I
Psilocybin..............................            7437               I
Psilocyn................................            7438               I
------------------------------------------------------------------------

    The company plans to bulk manufacture the above listed controlled 
substances for research and development purposes internally and for 
distribution to its research customers. No other activities for these 
drug codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-31293 Filed 12-27-24; 8:45 am]
BILLING CODE 4410-09-P


</pre></body>
</html>
Indexed from Federal Register on December 30, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.